XML 40 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Financial Instruments (Tables)
6 Months Ended
Jun. 30, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Effect of Net Investment Hedges on OCI and the Consolidated Statement of Income
The effects of the Company’s net investment hedges on OCI and the Consolidated Statement of Income are shown below:
 
Amount of Pretax (Gain) Loss Recognized in Other Comprehensive Income (1)
 
Amount of Pretax (Gain) Loss Recognized in Other (income) expense, net for Amounts Excluded from Effectiveness Testing
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
Three Months Ended June 30,
 
Six Months Ended June 30,
($ in millions)
2020
 
2019
 
2020
 
2019
 
2020
 
2019
 
2020
 
2019
Net Investment Hedging Relationships
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
$
8

 
$
17

 
$
5

 
$
7

 
$
(4
)
 
$
(8
)
 
$
(11
)
 
$
(15
)
Euro-denominated notes
72

 
28

 
21

 
(2
)
 

 

 

 

(1) No amounts were reclassified from AOCI into income related to the sale of a subsidiary.
Summary of Interest Rate Swaps Held At June 30, 2020, the Company was a party to 14 pay-floating, receive-fixed interest rate swap contracts designated as fair value hedges of fixed-rate notes in which the notional amounts match the amount of the hedged fixed-rate notes as detailed in the table below.
 
June 30, 2020
($ in millions)
Par Value of Debt
 
Number of Interest Rate Swaps Held
 
Total Swap Notional Amount
3.875% notes due 2021
$
1,150

 
5

 
$
1,150

2.40% notes due 2022
1,000

 
4

 
1,000

2.35% notes due 2022
1,250

 
5

 
1,250

Amounts Recorded on Balance Sheet Related to Fair Value Hedges
The table below presents the location of amounts recorded on the Consolidated Balance Sheet related to cumulative basis adjustments for fair value hedges:
 
Carrying Amount of Hedged Liabilities
 
Cumulative Amount of Fair Value Hedging Adjustment Increase (Decrease) Included in the Carrying Amount
($ in millions)
June 30, 2020
 
December 31, 2019
 
June 30, 2020
 
December 31, 2019
Balance Sheet Line Item in which Hedged Item is Included
 
 
 
 
 
 
 
Loans payable and current portion of long-term debt
$
1,160

 
$
1,249

 
$
10

 
$
(1
)
Long-Term Debt
2,318

 
3,409

 
71

 
14

Fair Value of Derivatives on a Gross Basis Segregated between those Derivatives that are Designated as Hedging Instruments and those that are Not Designated as Hedging Instruments
Presented in the table below is the fair value of derivatives on a gross basis segregated between those derivatives that are designated as hedging instruments and those that are not designated as hedging instruments:
 
 
June 30, 2020
 
December 31, 2019
 
 
Fair Value of Derivative
 
U.S. Dollar
Notional
 
Fair Value of Derivative
 
U.S. Dollar
Notional
($ in millions)
Balance Sheet Caption
Asset
 
Liability
 
Asset
 
Liability
 
Derivatives Designated as Hedging Instruments
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swap contracts
Other current assets
$
10

 
$

 
$
1,150

 
$

 
$

 
$

Interest rate swap contracts
Other Assets
72

 

 
2,250

 
15

 

 
3,400

Interest rate swap contracts
Accrued and other current liabilities

 

 

 

 
1

 
1,250

Foreign exchange contracts
Other current assets
83

 

 
4,959

 
152

 

 
6,117

Foreign exchange contracts
Other Assets
70

 

 
1,993

 
55

 

 
2,160

Foreign exchange contracts
Accrued and other current liabilities

 
27

 
1,884

 

 
22

 
1,748

Foreign exchange contracts
Other Noncurrent Liabilities

 
1

 
11

 

 
1

 
53

 
 
$
235


$
28


$
12,247


$
222


$
24


$
14,728

Derivatives Not Designated as Hedging Instruments
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
Other current assets
$
93

 
$

 
$
5,324

 
$
66

 
$

 
$
7,245

Foreign exchange contracts
Accrued and other current liabilities

 
103

 
5,865

 

 
73

 
8,693

 
 
$
93

 
$
103

 
$
11,189

 
$
66

 
$
73

 
$
15,938

 
 
$
328


$
131


$
23,436


$
288


$
97


$
30,666


Information on Derivative Positions Subject to Master Netting Arrangements as if they were Presented on a Net Basis The following table provides information on the Company’s derivative positions subject to these master netting arrangements as if they were presented on a net basis, allowing for the right of offset by counterparty and cash collateral exchanged per the master agreements and related credit support annexes:
 
June 30, 2020
 
December 31, 2019
($ in millions)
Asset
 
Liability
 
Asset
 
Liability
Gross amounts recognized in the condensed consolidated balance sheet
$
328

 
$
131

 
$
288

 
$
97

Gross amounts subject to offset in master netting arrangements not offset in the condensed consolidated balance sheet
(115
)
 
(115
)
 
(84
)
 
(84
)
Cash collateral received
(38
)
 

 
(34
)
 

Net amounts
$
175

 
$
16

 
$
170

 
$
13


Location and Amount of Pretax (Gains) Losses of Derivatives
The table below provides information regarding the location and amount of pretax (gains) losses of derivatives designated in fair value or cash flow hedging relationships:
 
Sales
 
Other (income) expense, net (1)
 
Other comprehensive income (loss)
 
Sales
 
Other (income) expense, net (1)
 
Other comprehensive income (loss)
 
Three Months Ended June 30,
 
Three Months Ended June 30,
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
Six Months Ended June 30,
 
Six Months Ended June 30,
($ in millions)
2020
 
2019
 
2020
 
2019
 
2020
 
2019
 
2020
 
2019
 
2020
 
2019
 
2020
 
2019
Financial Statement Line Items in which Effects of Fair Value or Cash Flow Hedges are Recorded
$
10,872

 
$
11,760

 
$
(390
)
 
$
140

 
$
(2
)
 
$
(16
)
 
$
22,929

 
$
22,575

 
$
(318
)
 
$
327

 
$
(200
)
 
$
183

(Gain) loss on fair value hedging relationships
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest rate swap contracts
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hedged items

 

 
1

 
55

 

 

 

 

 
68

 
88

 

 

Derivatives designated as hedging instruments

 

 
(8
)
 
(45
)
 

 

 

 

 
(76
)
 
(68
)
 

 

Impact of cash flow hedging relationships
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amount of (loss) gain recognized in OCI on derivatives

 

 

 

 
(109
)
 
10

 

 

 

 

 
69

 
(2
)
Increase (decrease) in Sales as a result of AOCI reclassifications
42

 
75

 

 

 
(42
)
 
(75
)
 
88

 
119

 

 

 
(88
)
 
(119
)
Interest rate contracts
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amount of gain recognized in Other (income) expense, net on derivatives

 

 
(1
)
 
(1
)
 

 

 

 

 
(2
)
 
(2
)
 

 

Amount of loss recognized in OCI on derivatives

 

 

 

 
(1
)
 
(1
)
 

 

 

 

 
(2
)
 
(5
)
(1) Interest expense is a component of Other (income) expense, net.
Income Statement Effects of Derivatives Not Designated as Hedging Instruments
The table below provides information regarding the income statement effects of derivatives not designated as hedging instruments:
 
 
 
Amount of Derivative Pretax (Gain) Loss Recognized in Income
 
 
 
Three Months Ended June 30,
 
Six Months Ended June 30,
($ in millions)
Income Statement Caption
 
2020
 
2019
 
2020
 
2019
Derivatives Not Designated as Hedging Instruments
 
 
 
 
 
 
 
 
 
Foreign exchange contracts (1)
Other (income) expense, net
 
$
49

 
$
2

 
$
(131
)
 
$
120

Foreign exchange contracts (2)
Sales
 
4

 
(6
)
 
(3
)
 
4

Interest rate contracts (3)
Other (income) expense, net
 
9

 

 
9

 

(1) These derivative contracts mitigate changes in the value of remeasured foreign currency denominated monetary assets and liabilities attributable to changes in foreign currency exchange rates.
(2) These derivative contracts serve as economic hedges of forecasted transactions.
Information on Investments in Debt and Equity Securities
Information on investments in debt and equity securities is as follows:
 
June 30, 2020
 
December 31, 2019
 
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
 
Amortized
Cost
 
Gross Unrealized
 
Fair
Value
($ in millions)
Gains
 
Losses
 
Gains
 
Losses
 
U.S. government and agency securities
$
74

 
$

 
$

 
$
74

 
$
266

 
$
3

 
$

 
$
269

Foreign government bonds
2

 

 

 
2

 

 

 

 

Commercial paper

 

 

 

 
668

 

 

 
668

Corporate notes and bonds

 

 

 

 
608

 
13

 

 
621

Asset-backed securities

 

 

 

 
226

 
1

 

 
227

Total debt securities
$
76


$


$


$
76


$
1,768


$
17


$


$
1,785

Publicly traded equity securities (1)
 
 
 
 
 
 
1,307

 


 


 


 
838

Total debt and publicly traded equity securities








 
$
1,383

 








 
$
2,623


(1) Unrealized net (gains) losses recognized in Other (income) expense, net on equity securities still held at June 30, 2020 were $(464) million and $(469) million in the second quarter and first six months of 2020, respectively. Unrealized net losses (gains) recognized in Other (income) expense, net on equity securities still held at June 30, 2019 were $39 million and $(75) million in the second quarter and first six months of 2019, respectively.
Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
Financial assets and liabilities measured at fair value on a recurring basis are summarized below:
 
Fair Value Measurements Using
 
Fair Value Measurements Using
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
($ in millions)
June 30, 2020
 
December 31, 2019
Assets
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign government bonds
$

 
$
2

 
$

 
$
2

 
$

 
$

 
$

 
$

Commercial paper

 

 

 

 

 
668

 

 
668

Corporate notes and bonds

 

 

 

 

 
621

 

 
621

Asset-backed securities (1)

 

 

 

 

 
227

 

 
227

U.S. government and agency securities

 

 

 

 

 
209

 

 
209

Publicly traded equity securities
1,249

 

 

 
1,249

 
518

 

 

 
518

 
1,249


2




1,251


518


1,725




2,243

Other assets (2)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. government and agency securities
74

 

 

 
74

 
60

 

 

 
60

Publicly traded equity securities
58

 

 

 
58

 
320

 

 

 
320

 
132






132


380






380

Derivative assets (3)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Forward exchange contracts

 
142

 

 
142

 

 
169

 

 
169

Purchased currency options

 
104

 

 
104

 

 
104

 

 
104

Interest rate swaps

 
82

 

 
82

 

 
15

 

 
15

 


328




328




288




288

Total assets
$
1,381


$
330


$


$
1,711


$
898


$
2,013


$


$
2,911

Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Contingent consideration
$

 
$

 
$
798

 
$
798

 
$

 
$

 
$
767

 
$
767

Derivative liabilities (3)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Forward exchange contracts

 
128

 

 
128

 

 
95

 

 
95

Written currency options

 
3

 

 
3

 

 
1

 

 
1

Interest rate swaps

 

 

 

 

 
1

 

 
1

 

 
131

 

 
131

 

 
97

 

 
97

Total liabilities
$


$
131


$
798


$
929


$


$
97


$
767


$
864

(1) 
Primarily all of the asset-backed securities were highly rated (Standard & Poor’s rating of AAA and Moody’s Investors Service rating of Aaa), secured primarily by auto loan, credit card and student loan receivables, with weighted-average lives of primarily 5 years or less.
(2) 
Investments included in other assets are restricted as to use, including for the payment of benefits under employee benefit plans.
(3) 
The fair value determination of derivatives includes the impact of the credit risk of counterparties to the derivatives and the Company’s own credit risk, the effects of which were not significant.
Information About the Changes in Liabilities for Contingent Consideration
Summarized information about the changes in liabilities for contingent consideration associated with business acquisitions is as follows:
 
Six Months Ended June 30,
($ in millions)
2020
 
2019
Fair value January 1
$
767

 
$
788

Additions
97

 

Changes in estimated fair value (1)
40

 
50

Payments
(106
)
 
(85
)
Fair value June 30 (2)(3)
$
798

 
$
753

(1) Recorded in Cost of sales, Research and development expenses, and Other (income) expense, net. Includes cumulative translation adjustments.
(2) Balance at June 30, 2020 includes $138 million recorded as a current liability for amounts expected to be paid within the next 12 months.
(3) At June 30, 2020 and December 31, 2019, $608 million and $625 million, respectively, of the liabilities relate to the termination of the Sanofi-Pasteur MSD joint venture in 2016. As part of the termination, Merck recorded a liability for contingent future royalty payments of 11.5% on net sales of all Merck products that were previously sold by the joint venture through December 31, 2024. The fair value of this liability is determined utilizing the estimated amount and timing of projected cash flows using a risk-adjusted discount rate of 8% to present value the cash flows.